Patents Assigned to Andrulis Pharmaceuticals - Justia Patents Search

Patents Assigned to Andrulis Pharmaceuticals

Treatment of inflammatory and/or autoimmune dermatoses with thalidomide alone or in combination with other agents

Patent number: 5654312

Abstract: Methods of treatment for inflammatory and autoimmune dermatoses which comprises topical and/or systemic administration of a therapeutically-effective amount of thalidomide alone or in combination with other dermatological agents.

Type: Grant

Filed: June 7, 1995

Date of Patent: August 5, 1997

Assignee: Andrulis Pharmaceuticals

Inventors: Peter J. Andrulis, Jr., Murray W. Drulak